CLINICAL TRIALS PROFILE FOR TAVAPADON
✉ Email this page to a colleague
Clinical Trials for Tavapadon
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT04201093 ↗ | Fixed-Dose Trial in Early Parkinson's Disease (PD) | Recruiting | Cerevel Therapeutics, LLC | Phase 3 | The purpose of this study is to evaluate the clinical efficacy, safety and pharmacokinetics (PK) of 2 fixed doses of tavapadon and placebo in participants with early PD. |
NCT04223193 ↗ | Flexible-Dose Trial in Early Parkinson's Disease (PD) | Recruiting | Cerevel Therapeutics, LLC | Phase 3 | The purpose of this study is to assess the efficacy, safety, tolerability and pharmacokinetics (PK) of flexible doses of tavapadon in participants with Parkinson's Disease. |
NCT04241393 ↗ | An Open-label Trial to Evaluate Mass Balance of Tavapadon at Steady State in Healthy Subjects | Completed | Cerevel Therapeutics, LLC | Phase 1 | The purpose of this trial is to determine the absorption, metabolism, and excretion (AME) of [14C] tavapadon. |
NCT04542499 ↗ | Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations | Recruiting | Cerevel Therapeutics, LLC | Phase 3 | The purpose of this study is to assess the effect of tavapadon on the change from baseline in total daily hours of "on" time without troublesome dyskinesia in L-Dopa-treated participants with Parkinson's Disease (PD) who are experiencing motor fluctuations. |
NCT04760769 ↗ | Open-label Trial in Parkinson's Disease (PD) | Recruiting | Cerevel Therapeutics, LLC | Phase 3 | The purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Parkinson's Disease. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Tavapadon
Condition Name
Clinical Trial Locations for Tavapadon
Trials by Country
Clinical Trial Progress for Tavapadon
Clinical Trial Phase
Clinical Trial Sponsors for Tavapadon
Sponsor Name